Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Am J Kidney Dis. 2013 Mar 15;62(2):236–244. doi: 10.1053/j.ajkd.2013.01.019

Table 4.

Outcomes during study period by race and projected kidney failure within study period.

Projected Kidney Failure ESRD Death
Black White Hispanic Asian Total Black White Hispanic Asian Total
Yes 501.19 (472.18–531.97) 213.91 (203.61–224.72) 444.22 (422.61–466.94) 468.48 (428.55–512.13) 333.73 (324.31–343.42) 1,068.68 (1,025.93–1,113.21) 1,513.73 (1,485,93–1,524.06) 785.73 (756.81–815.76) 793.71 (741.20–849.94) 1,212.32 (1,194.24–1,230.66)
No 0.90 (0.70–1.16) 0.60 (0.51–0.70) 0.33 (0.25–0.43) 0.43 (0.28–0.65) 0.54 (0.48–0.60) 89.39 (87.14–91.69) 127.10 (125.71–128.50) 45.05 (44.03–46.10) 44.51 (42.72–46.36) 89.47 (88.47–90.07)
Total 16.62 (15.69–17.62) 6.68 (6.38–7.01) 9.60 (9.14–10.08) 9.61 (8.81–10.49) 9.10 (8.85–9.36) 120.16 (117.59–122.78) 166.67 (165.11–168.25) 60.52 (59.35–61.72) 52.64 (57.17–61.32) 118.14 (117.23–119.05)

Note: Values shown as event rate per 10,000 person-years (95% CI). Projected kidney failure was defined by an ordinary least squares regression line that would result in estimated glomerular filtration rate<15 mL/min/1.73m2 within the study period (by 31st Dec 2009). Ninety-four percent of all participants experienced neither death nor ESRD within the study period.

CI, confidence interval; ESRD, end-stage renal disease;